Address: AVENIDA ENGENHEIRO BILLINGS, 1729 JAGUARÉ -SÃO PAULO – SP,Brazil
Tel: 11 3719-4566
Web: http://www.roche.com.br/portal/roche-brazil/inicio
Headquartered in Basel, Switzerland, Roche is one of the groups the world’s leading innovation in healthcare, working mainly in pharmaceuticals and diagnostics.
Roche is a leader in developing drugs to treat cancer, AIDS and transplantation, and is number one in the global diagnostics. The company contributes on several fronts to improve health and quality of life, developing products and services for the prevention, diagnosis and treatment of diseases.
Employing approximately 80,000 employees in 150 countries, Roche acts with responsibility and ethics, committing themselves to sustainable development and respect the needs of the individual, society and environment. Roche has alliances and research and development agreements with various partners, and majority shareholder of Chugai, a leader in the biotechnology sector.
Roche has been present in Brazil for over 80 years, and counts the country as its second fastest growing international affiliate.
Avastin, Herceptin, Rivotril
The government recently released the ‘BrasilMaior’ plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
Lauro Moretto, Emeritus President of the Brazilian Academy of Pharmaceutical Sciences and former Executive Vice-President of Sindusfarma provides insights into the main changes that have impacted Brazil’s pharmaceutical field over…
In an exclusive interview, Jarbas Barbosa da Silva, Director-President of the Brazilian Health Regulatory Agency (ANVISA), discusses some of the key specificities of the Brazilian market and highlights some of…
Dr. Wilson Pedreira, executive director of the Oncology and Hematology Center of the Albert Einstein Philanthropic Society in Brazil provides insights into the innovative healthcare model implemented in this cutting…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with the regulatory picture. In…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to sell pharmaceuticals, or the…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be in opposition. Can you…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these changes into a…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
We asked Mr. Santos regarding his recommendations to help the government innovate, compete, and grow in the pharmaceutical industry here in Brazil on the Human Genetic Therapies side. Is there…
See our Cookie Privacy Policy Here
